PubMed=1972348
Pfragner R., Hofler H., Behmel A., Ingolic E., Walser V.
Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma.
Cancer Res. 50:4160-4166(1990)

PubMed=12089864
Pfragner R., Wirnsberger G.H., Ingolic E., Niederle B.
Medullary thyroid carcinomas in cell culture -- models for future therapies.
Wien. Klin. Wochenschr. 114:279-283(2002)

PubMed=15126569; DOI=10.1210/jc.2003-031314
Kaczirek K., Schindl M., Weinhausel A., Scheuba C., Passler C., Prager G., Raderer M., Hamilton G., Mittlbock M., Siegl V., Pfragner R., Niederle B.
Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroid carcinoma cell lines.
J. Clin. Endocrinol. Metab. 89:2397-2401(2004)

PubMed=17786610; DOI=10.1080/14653240701385836
Stadler G., Wieser M., Steindl F., Grillari J., Katinger H., Pfragner R., Voglauer R.
Development of standarDIzed cell culture conditions for tumor cells with potential clinical application.
Cytotherapy 9:488-498(2007)

PubMed=22538498; DOI=10.1159/000338793
Grozinsky-Glasberg S., Shimon I., Rubinfeld H.
The role of cell lines in the study of neuroendocrine tumors.
Neuroendocrinology 96:173-187(2012)

CLPUB00412
Siddiqui Z.G.
Medullary thyroid cancer: the current state of tumour marker and treatment strategies.
Thesis MD (2015), Medical University of Graz, Austria